Cornerstone Select Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cornerstone Select Advisors's BMY Position: Q2 2026 in Review
Cornerstone Select Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.1% in Q2 2026, buying an estimated $22.6K and bringing the position to 19,000 shares worth $1.09M. The position accounts for 0.46% of the portfolio, ranked #62.
Cornerstone Select Advisors first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.78M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cornerstone Select Advisors held 19,000 shares of Bristol-Myers Squibb worth $1.09M as of Q2 2026.
- Cornerstone Select Advisors bought 393 Bristol-Myers Squibb shares in Q2 2026, an estimated $22.6K.
- Bristol-Myers Squibb made up 0.46% of Cornerstone Select Advisors's portfolio in Q2 2026, its #62 holding.
- Cornerstone Select Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Cornerstone Select Advisors's Bristol-Myers Squibb position peaked at $1.78M in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cornerstone Select Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.